<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30459302</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5.</ArticleTitle><Pagination><StartPage>185</StartPage><MedlinePgn>185</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41426-018-0186-y</ELocationID><Abstract><AbstractText>As one of the key members of the coxsackievirus B group, coxsackievirus B5 (CV-B5) can cause many central nervous system diseases, such as viral encephalitis, aseptic meningitis, and acute flaccid paralysis. Notably, epidemiological data indicate that outbreaks of CV-B5-associated central nervous system (CNS) diseases have been reported worldwide throughout history. In this study, which was conducted to promote CV-B5 vaccine and anti-virus drug research, a 3-day-old BALB/c mouse model was established using a CV-B5 clinical isolate (CV-B5/JS417) as the challenge strain. Mice challenged with CV-B5/JS417 exhibited a series of neural clinical symptoms and death with necrosis of neuronal cells in the cerebral cortex and the entire spinal cord, hindlimb muscles, and cardiomyocytes. The viral load of each tissue at various post-challenge time points suggested that CV-B5 replicated in the small intestine and was subsequently transmitted to various organs via viremia; the virus potentially entered the brain through the spinal axons, causing neuronal cell necrosis. In addition, this mouse model was used to evaluate the protective effect of a CV-B5 vaccine. The results indicated that both the inactivated CV-B5 vaccine and anti-CVB5 serum significantly protected mice from a lethal infection of CV-B5/JS417 by producing neutralizing antibodies. In summary, the first CV-B5 neonatal mouse model has been established and can sustain CNS infections in a manner similar to that observed in humans. This model will be a useful tool for studies on pathogenesis, vaccines, and anti-viral drug evaluations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Qunying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Xiaotian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yalin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Quality Control Department, Hualan Biological Engineering Inc., Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Ruixiao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Shuhui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shandong Xinbo Pharmaceutical Co. Ltd., Dezhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Lianlian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ce</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Bopei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Fengcai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lianzhong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shandong Xinbo Pharmaceutical Co. Ltd., Dezhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhenglun</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-6740-0864</Identifier><AffiliationInfo><Affiliation>Institute for Biological Products Control, National Institutes for Food and Drug Control, Beijing, China. lzhenglun@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016ZX09101120</GrantID><Agency>Ministry of Science and Technology of the People&amp;apos;s Republic of China (Chinese Ministry of Science and Technology)</Agency><Country/></Grant><Grant><GrantID>2018ZX09737011</GrantID><Agency>Ministry of Science and Technology of the People&amp;apos;s Republic of China (Chinese Ministry of Science and Technology)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022482">Cytomegalovirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002494" MajorTopicYN="N">Central Nervous System Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022482" MajorTopicYN="N">Cytomegalovirus Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Y. Hu is affiliated with Hualan Biological Engineering Inc., S. Lang and L. Shen are affiliated with Shandong Xinbo Pharmaceutical Co. Ltd. The remaining authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30459302</ArticleId><ArticleId IdType="pmc">PMC6246558</ArticleId><ArticleId IdType="doi">10.1038/s41426-018-0186-y</ArticleId><ArticleId IdType="pii">10.1038/s41426-018-0186-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg M, et al. Characterization of a putative ancestor of coxsackievirus B5. J. Virol. 2010;84:9695&#x2013;9708. doi: 10.1128/JVI.00071-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00071-10</ArticleId><ArticleId IdType="pmc">PMC2937801</ArticleId><ArticleId IdType="pubmed">20631132</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoelen I, et al. Molecular typing and epidemiology of enteroviruses identified from an out-break of aseptic meningitis in Belgium during the summer of 2000. J. Med. Virol. 2003;70:420&#x2013;429. doi: 10.1002/jmv.10412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10412</ArticleId><ArticleId IdType="pubmed">12767006</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa A, et al. Genetic variation of coxsackievirus B5 strains associated with aseptic meningitis in Greece. Clin. Microbiol. Infect. 2006;12:688&#x2013;691. doi: 10.1111/j.1469-0691.2006.01476.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2006.01476.x</ArticleId><ArticleId IdType="pubmed">16774571</ArticleId></ArticleIdList></Reference><Reference><Citation>Trallero G, et al. Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. J. Clin. Virol. 2010;47:170&#x2013;176. doi: 10.1016/j.jcv.2009.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.11.013</ArticleId><ArticleId IdType="pubmed">20007023</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos GP, et al. Enterovirus meningitis in Brazil, 1998-2003. J. Med. Virol. 2006;78:98&#x2013;104. doi: 10.1002/jmv.20509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20509</ArticleId><ArticleId IdType="pubmed">16299728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakoli NP, et al. Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis. J. Clin. Virol. 2008;43:207&#x2013;211. doi: 10.1016/j.jcv.2008.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2008.06.016</ArticleId><ArticleId IdType="pubmed">18692435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Novel and predominant pathogen responsible for the enterovirus-associated encephalitis in eastern China. PLoS ONE. 2013;8:e85023. doi: 10.1371/journal.pone.0085023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085023</ArticleId><ArticleId IdType="pmc">PMC3875553</ArticleId><ArticleId IdType="pubmed">24386442</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, et al. A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009. J. Med. Virol. 2013;85:483&#x2013;489. doi: 10.1002/jmv.23478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23478</ArticleId><ArticleId IdType="pubmed">23212939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, et al. An epidemic of encephalitis associated with human enterovirus B in Uttar Pradesh, India, 2008. J. Clin. Virol. 2011;51:142&#x2013;145. doi: 10.1016/j.jcv.2011.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.02.011</ArticleId><ArticleId IdType="pubmed">21444241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao CD, et al. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009. Emerg. Infect. Dis. 2012;18:1833&#x2013;1840. doi: 10.3201/eid1811.111457.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1811.111457</ArticleId><ArticleId IdType="pmc">PMC3559176</ArticleId><ArticleId IdType="pubmed">23092622</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith WG. Coxsackie B myopericarditis in adults. Am. Heart J. 1970;80:34&#x2013;46. doi: 10.1016/0002-8703(70)90035-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(70)90035-9</ArticleId><ArticleId IdType="pubmed">5426837</ArticleId></ArticleIdList></Reference><Reference><Citation>Helin M, et al. Cardiac manifestations during a coxsackie B5 epidemic. Br. Med. J. 1968;3:97&#x2013;99. doi: 10.1136/bmj.3.5610.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.3.5610.97</ArticleId><ArticleId IdType="pmc">PMC1986042</ArticleId><ArticleId IdType="pubmed">5662968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KW, et al. Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets. Diabetes. 2016;65:996&#x2013;1003. doi: 10.2337/db15-0956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-0956</ArticleId><ArticleId IdType="pubmed">26558682</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas H. Diabetes: enterovirus dysregulates islet miRNAs. Nat. Rev. Endocrinol. 2016;12:2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26610412</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres AS, et al. Transient broca aphasia in an elderly man caused by coxsackievirus B5. J. Neurol. 2002;249:1318&#x2013;1319. doi: 10.1007/s00415-002-0771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-002-0771-8</ArticleId><ArticleId IdType="pubmed">12242564</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, et al. Enterovirus surveillance--United States, 1970-2005. Mmwr. Surveill. Summ. 2006;55:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, et al. Coxsackievirus B5, associated with neurological hand, foot and mouth disease, China. J. Infect. 2012;65:189&#x2013;191. doi: 10.1016/j.jinf.2012.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2012.03.021</ArticleId><ArticleId IdType="pubmed">22484273</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, et al. Recombination of human coxsackievirus B5 in hand, foot, and mouth disease patients, China. Emerg. Infect. Dis. 2012;18:351&#x2013;353. doi: 10.3201/eid1802.111524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.111524</ArticleId><ArticleId IdType="pmc">PMC3310474</ArticleId><ArticleId IdType="pubmed">22305307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, et al. Full genome sequence of a novel coxsackievirus B5 strain isolated from neurological hand, foot, and mouth disease patients in China. J. Virol. 2012;86:11408&#x2013;11409. doi: 10.1128/JVI.01709-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01709-12</ArticleId><ArticleId IdType="pmc">PMC3457159</ArticleId><ArticleId IdType="pubmed">22997425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, et al. Recombination in human coxsackievirus B5 strains that caused an outbreak of viral encephalitis in Henan, China. Arch. Virol. 2013;158:2169&#x2013;2173. doi: 10.1007/s00705-013-1709-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1709-4</ArticleId><ArticleId IdType="pubmed">23624679</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control (CDC) Coxsackievirus B5 meningitis-Texas, 1983. Mmwr. Morb. Mortal. Wkly. Rep. 1984;33:281&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">6425630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecka H. Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States. Virus Res. 1995;38:125&#x2013;136. doi: 10.1016/0168-1702(95)00055-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00055-U</ArticleId><ArticleId IdType="pubmed">8578854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ST, et al. Molecular characterization of enteroviruses isolated from patients with aseptic meningitis in Korea, 2005. Arch. Virol. 2007;152:963&#x2013;970. doi: 10.1007/s00705-006-0901-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-006-0901-1</ArticleId><ArticleId IdType="pubmed">17238012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, et al. Genetic variation of coxsackievirus B5 strains associated with aseptic meningitis in Greece. Int. J. Infect. Dis. 2014;23:101&#x2013;104. doi: 10.1016/j.ijid.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.02.005</ArticleId><ArticleId IdType="pubmed">24747088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, et al. Recombination in human coxsac-kievirus B5 strains that caused an outbreak of viral encephalitis in Henan, China. Arch. Virol. 2013;158:2169&#x2013;2173. doi: 10.1007/s00705-013-1709-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1709-4</ArticleId><ArticleId IdType="pubmed">23624679</ArticleId></ArticleIdList></Reference><Reference><Citation>Colli ML, et al. Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim / Mcl-1 imbalance. PLoS Pathog. 2011;7:e1002267. doi: 10.1371/journal.ppat.1002267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002267</ArticleId><ArticleId IdType="pmc">PMC3178579</ArticleId><ArticleId IdType="pubmed">21977009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitahori, Y. et al. An epidemic of aseptic meningitis due to coxsackievirus B5 in Nara prefecture, Japan: an epidemiological analysis by PCR-RFLP. Jpn. J. Infect. Dis.56, 75&#x2013;76 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12824693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Identification and phylogenic analysis of Coxsackie-virus B5 during an outbreak of aseptic meningitis in Shandong. Zhonghua Liu Xing Bing. Xue Za Zhi. 2010;31:64&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">20302702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan BY, et al. Analysis on an outbreak investigation of viral meningitis caused by Cox B5virus. Prev. Med. Trib. 2007;13:11&#x2013;12.</Citation></Reference><Reference><Citation>Yen FB, et al. Coxsackieviruses infection in northern Taiwan-epidemiology and clinical characteristics. J. Microbiol. Immunol. Infect. 2009;42:38&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19424557</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon MS, et al. Distribution of viral RNA in mouse tissues during acute phase of coxsackievirus B5 infection. Intervirology. 2005;48:153&#x2013;160. doi: 10.1159/000082211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000082211</ArticleId><ArticleId IdType="pubmed">15812189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Q, et al. Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo. Arch. Virol. 2009;154:601&#x2013;607. doi: 10.1007/s00705-009-0346-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-009-0346-4</ArticleId><ArticleId IdType="pmc">PMC7086808</ArticleId><ArticleId IdType="pubmed">19291363</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland JM, et al. Attemps to infect pigs with Coxsackie virus type B5. J. Hyg. 1974;73:85&#x2013;96. doi: 10.1017/S0022172400023871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022172400023871</ArticleId><ArticleId IdType="pmc">PMC2130540</ArticleId><ArticleId IdType="pubmed">4529307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai SS, et al. Response of pigs to recent isolates of coxsackievirus B5. Comp. Immunol. Microbiol. Infect. Dis. 1979;2:459&#x2013;468. doi: 10.1016/0147-9571(79)90087-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0147-9571(79)90087-0</ArticleId><ArticleId IdType="pubmed">398243</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, et al. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis. J. Autoimmun. 2005;25:102&#x2013;111. doi: 10.1016/j.jaut.2005.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2005.05.007</ArticleId><ArticleId IdType="pubmed">16011890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. Coxsackievirus-induced acute neonatal central nervous system disease model. Int. J. Clin. Exp. Pathol. 2014;7:858&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971288</ArticleId><ArticleId IdType="pubmed">24696707</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong. ZP, et al. Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4. Zool. Res. 2018;39:52&#x2013;57. doi: 10.24272/j.issn.2095-8137.2017.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.24272/j.issn.2095-8137.2017.056</ArticleId><ArticleId IdType="pmc">PMC5869242</ArticleId><ArticleId IdType="pubmed">29511145</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui. CY, et al. Coxsackie virus B4 pericarditis in mice. Br. J. Exp. Pathol. 1971;52:47&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2072285</ArticleId><ArticleId IdType="pubmed">4926537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. Enterovirus 71: the virus, its infections and outbreaks. J. Microbiol. Immunol. Infect. 2000;33:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Enterovirus 71: epidemiology, pathogenesis and management. Expert. Rev. Anti. Infect. Ther. 2009;7:735&#x2013;742. doi: 10.1586/eri.09.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine. 2010;28:3516&#x2013;3521. doi: 10.1016/j.vaccine.2010.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.03.003</ArticleId><ArticleId IdType="pubmed">20304038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 2004;85:2981&#x2013;2989. doi: 10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, et al. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 2004;85:69&#x2013;77. doi: 10.1099/vir.0.19423-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, et al. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J. Gen. Virol. 2002;83:1707&#x2013;1720. doi: 10.1099/0022-1317-83-7-1707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-7-1707</ArticleId><ArticleId IdType="pubmed">12075090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S, et al. Recent insights into poliovirus pathogenesis. Trends Microbiol. 2001;9:501&#x2013;506. doi: 10.1016/S0966-842X(01)02200-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(01)02200-4</ArticleId><ArticleId IdType="pubmed">11597452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WX, et al. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology. 1997;229:421&#x2013;428. doi: 10.1006/viro.1997.8450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8450</ArticleId><ArticleId IdType="pubmed">9126254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R, et al. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 1992;166:747&#x2013;752. doi: 10.1093/infdis/166.4.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.4.747</ArticleId><ArticleId IdType="pubmed">1326581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostin LO. Mandatory vaccination: understanding the common good in the midst of the global polio eradication campaign. Isr. J. Health Policy Res. 2018;7:4. doi: 10.1186/s13584-017-0198-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-017-0198-4</ArticleId><ArticleId IdType="pmc">PMC5753519</ArticleId><ArticleId IdType="pubmed">29298727</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutter PD, et al. Transition planning for after polio eradication. J. Infect. Dis. 2017;216:S287&#x2013;S292. doi: 10.1093/infdis/jix026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix026</ArticleId><ArticleId IdType="pmc">PMC5853549</ArticleId><ArticleId IdType="pubmed">28838183</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, et al. EV71vaccine, an invaluable gift for children. Clin. Transl. Immunol. 2014;3:e28. doi: 10.1038/cti.2014.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2014.24</ArticleId><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, et al. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert. Rev. Vaccin. 2016;15:599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, et al. Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China. Hum. Vaccin. Immunother. 2018;14:74&#x2013;80. doi: 10.1080/21645515.2017.1384107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2017.1384107</ArticleId><ArticleId IdType="pmc">PMC5791574</ArticleId><ArticleId IdType="pubmed">29049009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M, et al. 2-Year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy chinese children: a randomized open-label study. J. Infect. Dis. 2017;215:56&#x2013;63. doi: 10.1093/infdis/jiw502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw502</ArticleId><ArticleId IdType="pubmed">28077584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. Hum. Vaccin. Immunother. 2017;13:823&#x2013;830. doi: 10.1080/21645515.2016.1236879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2016.1236879</ArticleId><ArticleId IdType="pmc">PMC5404359</ArticleId><ArticleId IdType="pubmed">27768527</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, et al. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 1938;27:493&#x2013;497. doi: 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, et al. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J. Virol. 2012;86:11967&#x2013;11976. doi: 10.1128/JVI.00902-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>